Search results
Fact check: Trump falsely claims Biden didn’t lower Americans’ insulin costs – KION546
KION 46 Salinas· 4 days agoPresident Joe Biden is campaigning on his success in getting seniors with diabetes a $35-per-month...
Biden plan to save Medicare patients money on drugs risks empty shelves, pharmacists say
Missouri Independent via Yahoo News· 6 days agoMonths into a new Biden administration policy intended to lower drug costs for Medicare patients,...
Here are four reasons Medicare drug-price "negotiation" in NJ isn't truly a negotiation.
Gannett via AOL· 5 days agoFour reasons Medicare drug-price "negotiation" isn't truly a negotiation. For 2024, New Jersey...
Jill Biden to visit Reno on Friday to launch effort to mobilize seniors
Reno Gazette-Journal· 6 days agoCalled “Seniors for Biden-Harris,” the effort will involve touting Biden’s actions such as capping...
Sales tax holiday set for Aug. 10 and 11 - The Boston Globe
The Boston Globe· 5 days agoThe rapidly rising cost of GLP-1 weight loss drugs is starting to weigh on policymakers in...
Ask Kevin: Due to income, Medicare payment is high. Should I keep it?
Federal Times· 4 days agoMy husband is 80 and is also covered under my FEHB insurance. Due to our income, our Medicare payments will be very high: more than $12,000 ...
Two Greensboro council members, seniors campaign for Biden, blast Trump
Greensboro News & Record· 6 days agoSpeakers at the event highlighted some of the Biden administration’s efforts in areas such as health...
New HSA Contribution Limits For 2025 Announced
Forbes· 7 days agoThe tax advantages of a Health Savings Account can be huge. All the same, optimizing your HSA can be a smart addition to your well-thought-out retirement...
States struggle to help patients navigate insurance hurdle known as ‘step therapy’
Missouri Independent via Yahoo News· 2 days agoCassidy Yermal, 32, began experiencing debilitating migraines when she was 17 years old. As a...
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
CNBC· 1 day agoSkyrocketing demand for a class of weight loss and diabetes treatments has lifted Eli Lilly to new...